Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rapid Renal Sympathetic Denervation for Resistant Hypertension Using the OneShot Renal Denervation System II

NCT01939392 is registered in ClinicalTrials.gov with Medtronic Endovascular as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01939392 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rapid Renal Sympathetic Denervation for Resistant Hypertension Using the OneShot Renal Denervation System II
Lead sponsor
Medtronic Endovascular
Phase
Phase 2/3
Overall status
Withdrawn
Start date
September 30, 2013
Completion date
September 30, 2018
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal artery ablation, resistant hypertension, uncontrolled hypertension